Replies to post #40690 on Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

In conclusion, our findings strengthen the antiretroviral potential of VIP and PACAP and point to new therapeutic approaches to control the progression of HIV-1 infection.

https://www.frontiersin.org/articles/10.3389/fimmu.2018.01336/full

The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one of the most challenging public health issues worldwide.

https://www.grandviewresearch.com/press-release/global-human-immunodeficiency-virus-hiv-1-therapeutics-market